1050 related articles for article (PubMed ID: 19404956)
21. Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via Fc gamma RIIa.
Porges AJ; Redecha PB; Kimberly WT; Csernok E; Gross WL; Kimberly RP
J Immunol; 1994 Aug; 153(3):1271-80. PubMed ID: 8027554
[TBL] [Abstract][Full Text] [Related]
22. The presence of membrane Proteinase 3 in neutrophil lipid rafts and its colocalization with FcgammaRIIIb and cytochrome b558.
David A; Fridlich R; Aviram I
Exp Cell Res; 2005 Aug; 308(1):156-65. PubMed ID: 15916759
[TBL] [Abstract][Full Text] [Related]
23. Anti-proteinase 3 antibodies (c-ANCA) prime CD14-dependent leukocyte activation.
Hattar K; van Bürck S; Bickenbach A; Grandel U; Maus U; Lohmeyer J; Csernok E; Hartung T; Seeger W; Grimminger F; Sibelius U
J Leukoc Biol; 2005 Oct; 78(4):992-1000. PubMed ID: 16006536
[TBL] [Abstract][Full Text] [Related]
24. Antineutrophil cytoplasmic antibodies reacting with the pro form of proteinase 3 and disease activity in patients with Wegener's granulomatosis and microscopic polyangiitis.
Russell KA; Fass DN; Specks U
Arthritis Rheum; 2001 Feb; 44(2):463-8. PubMed ID: 11229478
[TBL] [Abstract][Full Text] [Related]
25. Membrane proteinase 3 expression and ANCA-induced neutrophil activation.
Schreiber A; Luft FC; Kettritz R
Kidney Int; 2004 Jun; 65(6):2172-83. PubMed ID: 15149330
[TBL] [Abstract][Full Text] [Related]
26. Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
Harper L; Cockwell P; Adu D; Savage CO
Kidney Int; 2001 May; 59(5):1729-38. PubMed ID: 11318943
[TBL] [Abstract][Full Text] [Related]
27. Proteinase 3 expression on neutrophil membranes from patients with infectious disease.
Matsumoto T; Kaneko T; Wada H; Kobayashi T; Abe Y; Nobori T; Shiku H; Stearns-Kurosawa DJ; Kurosawa S
Shock; 2006 Aug; 26(2):128-33. PubMed ID: 16878019
[TBL] [Abstract][Full Text] [Related]
28. c-ANCA-induced neutrophil-mediated lung injury: a model of acute Wegener's granulomatosis.
Hattar K; Oppermann S; Ankele C; Weissmann N; Schermuly RT; Bohle RM; Moritz R; Krögel B; Seeger W; Grimminger F; Sibelius U; Grandel U
Eur Respir J; 2010 Jul; 36(1):187-95. PubMed ID: 20032014
[TBL] [Abstract][Full Text] [Related]
29. Human anti-neutrophil cytoplasm autoantibodies to proteinase 3 (PR3-ANCA) bind to neutrophils.
Van Rossum AP; van der Geld YM; Limburg PC; Kallenberg CG
Kidney Int; 2005 Aug; 68(2):537-41. PubMed ID: 16014030
[TBL] [Abstract][Full Text] [Related]
30. Lessons from a double-transgenic neutrophil approach to induce antiproteinase 3 antibody-mediated vasculitis in mice.
Schreiber A; Eulenberg-Gustavus C; Bergmann A; Jerke U; Kettritz R
J Leukoc Biol; 2016 Dec; 100(6):1443-1452. PubMed ID: 27365530
[TBL] [Abstract][Full Text] [Related]
31. 'Classic' anti-neutrophil cytoplasmic autoantibodies (cANCA), 'Wegener's autoantigen' and their immunopathogenic role in Wegener's granulomatosis.
Gross WL; Csernok E; Flesch BK
J Autoimmun; 1993 Apr; 6(2):171-84. PubMed ID: 8388690
[TBL] [Abstract][Full Text] [Related]
32. Neutrophil-specific antigen HNA-2a, NB1 glycoprotein, and CD177.
Stroncek DF
Curr Opin Hematol; 2007 Nov; 14(6):688-93. PubMed ID: 17898576
[TBL] [Abstract][Full Text] [Related]
33. Anti-neutrophil cytoplasm antibody IgG subclasses in Wegener's granulomatosis: a possible pathogenic role for the IgG4 subclass.
Holland M; Hewins P; Goodall M; Adu D; Jefferis R; Savage CO
Clin Exp Immunol; 2004 Oct; 138(1):183-92. PubMed ID: 15373923
[TBL] [Abstract][Full Text] [Related]
34. NB1 mediates surface expression of the ANCA antigen proteinase 3 on human neutrophils.
von Vietinghoff S; Tunnemann G; Eulenberg C; Wellner M; Cristina Cardoso M; Luft FC; Kettritz R
Blood; 2007 May; 109(10):4487-93. PubMed ID: 17244676
[TBL] [Abstract][Full Text] [Related]
35. Subthreshold concentrations of anti-proteinase 3 antibodies (c-ANCA) specifically prime human neutrophils for fMLP-induced leukotriene synthesis and chemotaxis.
Hattar K; Sibelius U; Bickenbach A; Csernok E; Seeger W; Grimminger F
J Leukoc Biol; 2001 Jan; 69(1):89-97. PubMed ID: 11200073
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides.
Kallenberg CG; Heeringa P; Stegeman CA
Nat Clin Pract Rheumatol; 2006 Dec; 2(12):661-70. PubMed ID: 17133251
[TBL] [Abstract][Full Text] [Related]
37. The use of small molecule high-throughput screening to identify inhibitors of the proteinase 3-NB1 interaction.
Choi M; Eulenberg C; Rolle S; von Kries JP; Luft FC; Kettritz R
Clin Exp Immunol; 2010 Aug; 161(2):389-96. PubMed ID: 20456416
[TBL] [Abstract][Full Text] [Related]
38. The membrane proteinase 3 expression on neutrophils was downregulated after treatment with infliximab in patients with rheumatoid arthritis.
Matsumoto T; Kaneko T; Seto M; Wada H; Kobayashi T; Nakatani K; Tonomura H; Tono Y; Ohyabu M; Nobori T; Shiku H; Sudo A; Uchida A; Kurosawa DJ; Kurosawa S
Clin Appl Thromb Hemost; 2008 Apr; 14(2):186-92. PubMed ID: 18372277
[TBL] [Abstract][Full Text] [Related]
39. Wegener's granulomatosis: antiproteinase 3 antibodies induce monocyte cytokine and prostanoid release-role of autocrine cell activation.
Hattar K; Bickenbach A; Csernok E; Rosseau S; Grandel U; Seeger W; Grimminger F; Sibelius U
J Leukoc Biol; 2002 Jun; 71(6):996-1004. PubMed ID: 12050185
[TBL] [Abstract][Full Text] [Related]
40. Increased neutrophil membrane expression and plasma level of proteinase 3 in systemic vasculitis are not a consequence of the - 564 A/G promotor polymorphism.
Abdgawad M; Hellmark T; Gunnarsson L; Westman KW; Segelmark M
Clin Exp Immunol; 2006 Jul; 145(1):63-70. PubMed ID: 16792675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
